GPR55 and rheumatoid arthritis: In our current research, we present novel evidence that the GPR55 antagonist CID16020046 can inhibit lipopolysaccharide-induced expression of pro-inflammatory cytokines in SW982 human synoviocytes and mitigate collagen-induced rheumatoid arthritis in DBA-1J mice.